(July 11, 2017, 1:53 PM EDT) -- SAN FRANCISCO — Relying on the U.S. Supreme Court’s ruling in Universal Health Services, Inc. v. United States, ex rel Escobar, __ U.S. __, , 136 S. Ct. 1989 (2016), the Ninth Circuit U.S. Court of Appeals on July 7 reversed dismissal of a False Claims Act/retaliation claim alleging that drug maker Gilead Sciences Inc. used unapproved and contaminated ingredients in its HIV drugs (United States of America, ex rel. Jeffrey Campie, et al. v. Gilead Sciences, Inc., No. 15-16380, 9th Cir., 2017 U.S. App. LEXIS 12163)....